AzTrials
AzTrials

Women's Health: Neoplasm of BreastPRECAM-2NCT04396665

Breast Cancer: Feasibility of an Educational Intervention

A study testing Precam in people with Women's Health: Neoplasm of Breast, run by University of Oviedo at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Aim: To evaluate the viability of an educational intervention for the prevention of breast cancer risk and the modification of their risk behaviors through the use of a web application in women living in the Principality of Asturias. Design: pilot test Population: 300 women without breast cancer living in Asturias. Read more about this study

Who is it for?
Ages 25 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Women's Health: Neoplasm of Breast
What is being tested?
Precam
Could I receive a placebo?
No, everyone receives an active treatment
How many people
224 participants
Where
1 siteSpain
Study dates
1 Dec 2019to 9 Nov 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Informed consent signed
  • Capability to use internet

Who cannot join

  • Breast cancer diagnosis duting the intervention

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • University of Oviedo

    Oviedo, Principality of Asturias, 33006

Other trials in Spain

About this study

Official title: Feasibility of an Educational Intervention for the Prevention of Breast Cancer by Modifying Risk Behaviors Through a Web Application

Aim: To evaluate the viability of an educational intervention for the prevention of breast cancer risk and the modification of their risk behaviors through the use of a web application in women living in the Principality of Asturias.

Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. Informed consent signed.

Read more

Variables: personal characteristics (age, status, educational level, occupation), MIC index, dietary characteristics, level of physical activity, presence of known risks of breast cancer (number of children, breastfeeding, oral contraceptives, family history of cancer, previous cancer, breast density and knowledge related with breast cancer prevention.

Intervention:

  • Intervention Group:6 months intervention using a web-app related with personal care and breast cancer risks, diet and physical activity.
  • Control Group: no intervention.
Read the detailed description

Aim: To evaluate the viability of an educational intervention for the prevention of breast cancer risk and the modification of their risk behaviors through the use of a web application in women living in the Principality of Asturias.

Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. They are recluted for a previous study developed by the same research team. An information document and a written consent was given for the women. Those who signed the consent are included.

The randomization for intervention or control group are doing based on the where the city where the women home is located. the objective of this distribution is to avoid contact between women from different groups.

Variables: personal characteristics (age, status, educational level, civil status), MIC index, dietary characteristics, level of physical activity, knowledge related with breast cancer symptoms and risk factors.

Intervention:

The 6 months intervention are going to be developed using a web-app. The intervention is based on the Behavior Change Wheel model. Capacity and motivation are going to be the determinants on which it will work using for it interventions based on education, persuasion and modeling among others.

Intervention Group: 6 months intervention using a web-app related. The web-app includes some sections:

  • Information related with breast cancer risk.
  • Breast self examination. Written text and videos done by a nurse.
  • Physical exercise. Written text and videos done by a physiotherapist .
  • Dietary information. Written text and videos done by a nutrition expert.

The Control Group are not going to receive intervention during the study period time. After that, women are going to be access to the web-app.

Statistical analysis

Descriptive statistics will be carried out (means, standard deviation, CI and percentages). In addition, at the end of the study, in order to determine the factibility of the educational intervention, the variation of the intra-group data (from pre to psot-test) and between the groups in post-test will be compared using the chi-square test. , t-student or Mann-Whitney U, for qualitative or quantitative data respectively.

Being tested
Precam
Keywords
Breast neoplasm, Health Promotion, Dietary, Phycical activity, Breast cancer risk
Medical subject headings
Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PrecamBehavioural

    6 months Web-App intervention related with: diet, physical activity, self-care and breast cacner risk prevention

Study groups in NCT04396665
Study groupRoleWhat they receive
Precam Group (Intervention Group)Experimental150 Women without breast cancer, aged from 25 to 50 years old
Receives: Behavioral: Precam
Control GroupNo intervention150 Women without breast cancer, aged from 25 to 50 years old

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of an Educational Intervention: Adherence to the Intervention

    Participants that finish the intervention

    Measured: 6 months

  2. Feasibility of an Educational Intervention: Drop Out After the Intervention Period

    People that did not finish the intervention

    Measured: 6 months

  3. Number of Diet and Activity Recommendations

    Mean number of recommendations done by the participants

    Measured: 6 months

  4. Breast Cancer Awareness

    Using 2 dimensions of MARA questionnaire (Scale title)1) knowledge of risk factors of breast cancer (range 0=worst score to 9=better score); 2) knowledge of signs and symptoms of breast cancer (range 0=worst score to 9=better score)

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 May 2020
  2. Study start1 Dec 2019
  3. Primary completion31 Jan 2020
  4. Study completion9 Nov 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
224 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04396665
Sponsor's protocol ID
147/19
Acronym
PRECAM-2
Status last verified
Aug 2021
First submitted
29 Mar 2020
Last updated
20 Aug 2021
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Anonymizes data are going to be published but we are not going to analizase individual data.

Questions about this trial

What is this clinical trial studying?

A study testing Precam in people with Women's Health: Neoplasm of Breast, run by University of Oviedo at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Aug 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of an Educational Intervention: Adherence to the Intervention (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in